Cancer Diagnostics Market Size, Share, Trends, Growth and Forecast Report 2021-2027

Description

The global Cancer Diagnostics market garnered revenue around USD 369,600.05 million in 2020 and projected to reach USD 382,692.23 million in 2027, with at a compound annual growth rate (CAGR) 7.11% throughout the estimate period from 2021 to 2027. Cancer diagnostics is a method of identifying different biomarkers, proteins, and some signs that lead to the identification of the presence of a cancerous tumor. Efficient diagnostic testing is used to validate or rule out the existence of illness, monitor the progression of the disease, and schedule & review treatment outcomes. Diagnostic procedures for cancer may include imaging, tumor biopsy, laboratory tests (including tests for tumor markers), endoscopic examination, surgery, or genetic testing.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Cancer Diagnostics market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Cancer Diagnostics market growth.

The global Cancer Diagnostics market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

The key players profiled in this report include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Roche Holdings AG (F. Hoffmann-La Roche Ltd.), Danaher Corporation (GE Healthcare), Hologic, Inc., Koninklijke Philips N.V. (Philips Healthcare), Qiagen N.V., Siemens Healthcare GmbH, and Thermo Fisher Scientific.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

By Product

·         Consumables

o    Antibodies

o    Kits & Reagents

o    Probes

o    Other Consumables

·         Instruments

o    Pathology-based Instruments

o    Imaging Instruments

o    Biopsy  Instruments

By Application

·         Breast Cancer

·         Colorectal Cancer

·         Cervical Cancer

·         Lung Cancer

·         Prostate Cancer

·         Skin Cancer

·         Blood Cancer

·         Kidney Cancer

·         Liver Cancer

·         Pancreatic Cancer

·         Ovarian Cancer

·         Others

By End Use

·         Hospitals and Clinics

·         Diagnostic Laboratories

·         Diagnostic Imaging Centers

·         Research Institutes 

List Of Key Players Profiled In The Report

·         Abbott Laboratories

·         Becton, Dickinson and Company

·         Bio-Rad Laboratories, Inc.

·         Roche Holdings AG (F. Hoffmann-La Roche Ltd.)

·         Danaher Corporation (GE Healthcare)

·         Hologic, Inc.

·         Koninklijke Philips N.V. (Philips Healthcare)

·         Qiagen N.V.

·         Siemens Healthcare GmbH

·         Thermo Fisher Scientific Inc.

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope: 

 

North America

United States

Canada

 

Europe

Germany

United Kingdom

Italy

France

Rest of EU

 

Asia Pacific

China

India

Japan

Southeast Asia

Rest of APAC

 

Central & South America 

Brazil 

Argentina

Rest of Central & South America 

 

Middle East and Africa

GCC

North Africa

South Africa

TABLE OF CONTENT

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Cancer Diagnostics Market, By Product

7.1.  Cancer Diagnostics Market, by Product, 2021-2027

7.1.1.    Consumables

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Instruments

7.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Cancer Diagnostics Market, By Application

8.1.  Cancer Diagnostics Market, by Application, 2021-2027

8.1.1.    Breast Cancer

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Colorectal Cancer

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Cervical Cancer

8.1.3.1.        Market Revenue and Forecast (2016-2027)

8.1.4.    Lung Cancer

8.1.4.1.        Market Revenue and Forecast (2016-2027)

8.1.5.    Prostate Cancer

8.1.5.1.        Market Revenue and Forecast (2016-2027)

8.1.6.    Skin Cancer

8.1.6.1.        Market Revenue and Forecast (2016-2027)

8.1.7.    Blood Cancer

8.1.7.1.        Market Revenue and Forecast (2016-2027)

8.1.8.    Kidney Cancer

8.1.8.1.        Market Revenue and Forecast (2016-2027)

8.1.9.    Liver Cancer

8.1.9.1.        Market Revenue and Forecast (2016-2027)

8.1.10.  Liver Cancer

8.1.10.1.      Market Revenue and Forecast (2016-2027)

8.1.11.  Ovarian Cancer

8.1.11.1.      Market Revenue and Forecast (2016-2027)

8.1.12.  Others

8.1.12.1.      Market Revenue and Forecast (2016-2027)

Chapter 9.  Global Cancer Diagnostics Market, By End User

9.1.  Cancer Diagnostics Market, by End User, 2021-2027

9.1.1.    Hospitals and Clinics

9.1.1.1.        Market Revenue and Forecast (2016-2027)

9.1.2.    Diagnostic Laboratories

9.1.2.1.        Market Revenue and Forecast (2016-2027)

9.1.3.    Diagnostic Imaging Centers

9.1.3.1.        Market Revenue and Forecast (2016-2027)

9.1.4.    Research Institutes

9.1.4.1.        Market Revenue and Forecast (2016-2027)

Chapter 10.      Global Cancer Diagnostics Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Product (2016-2027)

10.1.2.  Market Revenue and Forecast, by Application (2016-2027)

10.1.3.  Market Revenue and Forecast, by End User (2016-2027)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Product (2016-2027)

10.1.4.2.      Market Revenue and Forecast, by Application (2016-2027)

10.1.4.3.      Market Revenue and Forecast, by End User (2016-2027)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Product (2016-2027)

10.1.5.2.      Market Revenue and Forecast, by Application (2016-2027)

10.1.5.3.      Market Revenue and Forecast, by End User (2016-2027)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Product (2016-2027)

10.2.2.  Market Revenue and Forecast, by Application (2016-2027)

10.2.3.  Market Revenue and Forecast, by End User (2016-2027)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Product (2016-2027)

10.2.4.2.      Market Revenue and Forecast, by Application (2016-2027)

10.2.4.3.      Market Revenue and Forecast, by End User (2016-2027)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Product (2016-2027)

10.2.5.2.      Market Revenue and Forecast, by Application (2016-2027)

10.2.5.3.      Market Revenue and Forecast, by End User (2016-2027)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Product (2016-2027)

10.2.6.2.      Market Revenue and Forecast, by Application (2016-2027)

10.2.6.3.      Market Revenue and Forecast, by End User (2016-2027)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Product (2016-2027)

10.2.7.2.      Market Revenue and Forecast, by Application (2016-2027)

10.2.7.3.      Market Revenue and Forecast, by End User (2016-2027)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Product (2016-2027)

10.3.2.  Market Revenue and Forecast, by Application (2016-2027)

10.3.3.  Market Revenue and Forecast, by End User (2016-2027)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Product (2016-2027)

10.3.4.2.      Market Revenue and Forecast, by Application (2016-2027)

10.3.4.3.      Market Revenue and Forecast, by End User (2016-2027)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Product (2016-2027)

10.3.5.2.      Market Revenue and Forecast, by Application (2016-2027)

10.3.5.3.      Market Revenue and Forecast, by End User (2016-2027)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Product (2016-2027)

10.3.6.2.      Market Revenue and Forecast, by Application (2016-2027)

10.3.6.3.      Market Revenue and Forecast, by End User (2016-2027)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Product (2016-2027)

10.3.7.2.      Market Revenue and Forecast, by Application (2016-2027)

10.3.7.3.      Market Revenue and Forecast, by End User (2016-2027)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Product (2016-2027)

10.4.2.  Market Revenue and Forecast, by Application (2016-2027)

10.4.3.  Market Revenue and Forecast, by End User (2016-2027)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Product (2016-2027)

10.4.4.2.      Market Revenue and Forecast, by Application (2016-2027)

10.4.4.3.      Market Revenue and Forecast, by End User (2016-2027)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Product (2016-2027)

10.4.5.2.      Market Revenue and Forecast, by Application (2016-2027)

10.4.5.3.      Market Revenue and Forecast, by End User (2016-2027)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Product (2016-2027)

10.4.6.2.      Market Revenue and Forecast, by Application (2016-2027)

10.4.6.3.      Market Revenue and Forecast, by End User (2016-2027)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Product (2016-2027)

10.4.7.2.      Market Revenue and Forecast, by Application (2016-2027)

10.4.7.3.      Market Revenue and Forecast, by End User (2016-2027)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Product (2016-2027)

10.5.2.  Market Revenue and Forecast, by Application (2016-2027)

10.5.3.  Market Revenue and Forecast, by End User (2016-2027)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Product (2016-2027)

10.5.4.2.      Market Revenue and Forecast, by Application (2016-2027)

10.5.4.3.      Market Revenue and Forecast, by End User (2016-2027)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Product (2016-2027)

10.5.5.2.      Market Revenue and Forecast, by Application (2016-2027)

10.5.5.3.      Market Revenue and Forecast, by End User (2016-2027)

Chapter 11.  Company Profiles

11.1.              Abbott Laboratories

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Becton

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Dickinson and Company

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Bio-Rad Laboratories, Inc.

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Roche Holdings AG (F. Hoffmann-La Roche Ltd.)

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Danaher Corporation (GE Healthcare)

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Hologic, Inc.

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Koninklijke Philips N.V. (Philips Healthcare)

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Qiagen N.V.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Siemens Healthcare GmbH

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

11.11.           Thermo Fisher Scientific.

11.11.1.               Company Overview

11.11.2.               Product Offerings

11.11.3.               Financial Performance

11.11.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

 

13.2.              Glossary of Terms

Choose License Type

Checkout Inquiry Sample